Welcome
By selecting the Yes, leave Opcaseportalsg.com option you understand that you are leaving the website and that you will be redirected to another Internet site belonging to third parties, for whose content or opinions Amgen Singapore is not responsible and makes no representations regarding such content or its accuracy. By selecting this option and accessing linked third-party sites, you understand that you do so at your own risk.
The website to which you will be redirected may be designed exclusively for residents of a particular country or countries, as advertised on that website. As a consequence, the website to which you will be directed may contain information on pharmaceutical products or indications that are not approved in Singapore. If you reside in a country other than the one to which such website is directed, please contact your local Amgen affiliate for the correct information on products in your country of residence.
Case contributed by Clin Assoc Prof Reuben Soh Chee Cheong, Senior Consultant in Orthopaedic Surgery, Singapore General Hospital
Patient Information
Age: 62 years
Sex: Female
Relevant patient demographics: Menopause at 55
-
History
Presenting complaint
- On follow up for osteoporotic vertebral compression fracture L1
- Found to have spinal stenosis L5/S1 with foraminal stenosis L5/S1
-
Investigation
Preoperative BMD
Preoperative MRI
- Foraminal stenosis of L5/S1
-
Treatment
Surgical
- Patient underwent surgery to correct for her stenosis
Pharmacological
- Patient was started on Romosozumab for 1 year, immediately after surgery
- After completion of romosozumab, patient was maintained on 6-monthly denosumab
-
Follow Up
Postoperative findings
- Imaging showed successful union of L5/S1
BMD after 1-year romosozumab
-
Summary
- Patient was found to have spinal stenosis L5/S1 with foraminal stenosis L5/S1 during a follow up for osteoporotic vertebral compression fracture L1
- Before surgery, patient had a T-score of -2.6, and imaging scans revealed foraminal stenosis of L5/S1
- Patient underwent surgery to correct for her stenosis. She was immediately started on romosozumab post-surgery.
- During follow-ups after surgery, imaging scans revealed
- successful union of L5/S1 post-surgery
- an improvement in BMD after taking romosozumab for 1 year.
- Patient was maintained on 6-monthly denosumab.
-
Abbreviations
BMD, bone mineral density; CT, computed tomography; MRI, magnetic resonance imaging
-
Important Safety Information:Osteoporosis Case BinderThis curated collection of patient case studies aims to provide healthcare practitioners in the area of bone health, with a comprehensive understanding of risk-based treatment approach in the long-term management of patients living with osteoporosis.The patient cases were contributed by bone health experts from respective clinical setting, incorporating evidence-based discussions, guidelines and clinical considerations in the individualised treatment sequencing plans of different real-world scenarios..Please review full product information before prescribingFor Healthcare Professionals Only.Please refer to full prescribing information prior to administrationFor information on Amgen products or to report an adverse event involving an Amgen product, please contact Medical Information at 800-616-7094 or medinfo.JAPAC@amgen.comSC-SGP-AMG162-00142-Apr2026